Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Treprostinil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 379,495Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    United Therapeutics Completes Enrollment for Treprostinil Study
    United Therapeutics Completes Enrollment for Treprostinil Study

    04 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250204276953/en

    BUSINESSWIRE
    04 Feb 2025
    Share Share
    United Therapeutics to Feature Data at CHEST 2024 Meeting
    United Therapeutics to Feature Data at CHEST 2024 Meeting

    24 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240924167810/en

    BUSINESSWIRE
    24 Sep 2024
    Share Share
    Liquidia Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity
    Liquidia Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity

    20 Aug 2024

    // BIOSPACE

    https://www.biospace.com/fda/liquida-misses-full-approval-for-pulmonary-hypertension-drug-as-competitor-retains-market-exclusivity

    BIOSPACE
    20 Aug 2024
    Share Share
    United Therapeutics Fully Enrolls TETON 2 Study For Inhaled Treprostinil
    United Therapeutics Fully Enrolls TETON 2 Study For Inhaled Treprostinil

    10 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240710696574/en

    BUSINESSWIRE
    10 Jul 2024
    Share Share
    Par Pharma recalls blood pressure med for possible contamination
    Par Pharma recalls blood pressure med for possible contamination

    22 Apr 2024

    // Joseph Keenan FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/endos-par-pharma-issues-recall-blood-pressure-med-due-possible-contamination

    Joseph Keenan FIERCE PHARMA
    22 Apr 2024
    Share Share
    Enforcement Report - Week of April 3, 2024
    Enforcement Report - Week of April 3, 2024

    03 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2024-41763.pdf

    FDA
    03 Apr 2024
    Share Share